1-1 of 1
R. Filshie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Higher-Dose Imatinib (600 mg/Day) with Selective Intensification in Newly Diagnosed CML Patients in Chronic Phase; Cytogenetic Response Rates at 12 Months Are Superior to IRIS.

Timothy Hughes, S. Branford, J. Reynolds, J. Seymour, K. Taylor, N. Guzzo-Pernell, R. Filshie, C. Arthur, A. Schwarer, M. Hertzberg, Z. Rudzki, M. Copeman, K. Lynch, A. Grigg
Journal: Blood
Blood (2004) 104 (11): 1001.
https://doi.org/10.1182/blood.V104.11.1001.1001
Published: 2004